topSkip to main content

Menu, Secondary

Menu Trigger

Menu

Reducing Regulatory Burden

While federal regulations and reporting requirements are mostly well intentioned, research universities are among the most regulated entities in the country and often must comply with regulations that are not sensible or scaled to risk.  The AAU works with the federal government to harmonize, streamline, and when possible eliminate unnecessary regulations and reporting requirements to maximize federal investments in research while still ensuring public accountability.  AAU also helps its member universities to review their existing institutional policies and procedures to ensure that they are not adding unnecessary and costly requirements on themselves.

 

A recent report from the National Academies of Sciences, Engineering, and Medicine (NASEM) emphasizes the need for immediate, system-wide change to reduce regulatory burdens on research.
AAU and APLU sent a joint letter to the Office of Management and Budget (OMB) in response to their RFI on Deregulation, where they "recommend several areas to simplify federal regulations to increase efficiency of the U.S. scientific enterprise and reduce unnecessary regulatory burdens on university researchers."
AAU joined CUPA-HR-led comments in response to the Labor Department’s proposed overtime rule, which formally rescinds the Department’s 2016 rule. The rule, published in March 2019, would increase the annual salary threshold that determines which employees qualify for overtime pay from $455 to $679 per week (equivalent to $35,308 per year).
AAU urges Congress and the Administration to harmonize, streamline, and eliminate unnecessary, duplicative regulations and reporting requirements.
AAU sent Trump's transition team a comprehensive set of policy recommendations aimed at helping the nation sustain its preeminence in research, innovation, and higher education.
AAU and COGR today issued a statement of support for draft legislation issued by Representative Lipinski to reduce the burden of federal regulation on research.
In the US, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.
On behalf of the Association of American Universities (AAU), I would like to thank you for the opportunity to provide comments to the Committee on Commerce, Science, and Transportation on the reauthorization of the America COMPETES Act.
The following testimony is for the record submitted to the United States Senate Committee on Finance Hearing on Higher Education and the Tax Code.
AAU President's statement on congressional approval of the Digital Accountability and Transparency (DATA) Act.